GLP-1 medication brands
Reference information on major GLP-1 brand medications and how they compare to compounded alternatives.
Ozempic: what it is, how it works, and alternatives
Ozempic is the brand name for injectable semaglutide manufactured by Novo Nordisk, FDA-approved for type 2 diabetes treatment. While frequently prescribed off-label for weight management, Ozempic is not specifically approved for that indication.
The goal is not endless browsing. Use these pages to clarify one question, then jump into the quiz once you have context.
Primary action
Use these pages to reach the quiz with intent.
A better SEO page does not stop at informing. It should move the patient into a more qualified evaluation.
Start evaluationOzempic: what it is, how it works, and alternatives
Ozempic is the brand name for injectable semaglutide manufactured by Novo Nordisk, FDA-approved for type 2 diabetes treatment. While frequently prescribed off-label for weight management, Ozempic is not specifically approved for that indication.
Wegovy: semaglutide approved for weight management
Wegovy is the brand name for higher-dose injectable semaglutide, FDA-approved specifically for chronic weight management in adults with obesity or overweight with comorbidities.
Zepbound: tirzepatide approved for weight management
Zepbound is the brand name for injectable tirzepatide manufactured by Eli Lilly, FDA-approved for chronic weight management. It acts on two receptors: GIP and GLP-1.
Mounjaro: tirzepatide for type 2 diabetes
Mounjaro is the brand name for injectable tirzepatide manufactured by Eli Lilly, approved for type 2 diabetes treatment. Like Zepbound, it acts on both GIP and GLP-1 receptors.
Rybelsus: oral semaglutide
Rybelsus is the brand name for oral semaglutide manufactured by Novo Nordisk, approved for type 2 diabetes treatment. It is the first oral formulation of a GLP-1 receptor agonist.